Literature DB >> 22748940

Workgroup on NAPA's scientific agenda for a national initiative on Alzheimer's disease.

.   

Abstract

This report outlines a goal-directed scientific agenda for a national initiative to overcome the Alzheimer's disease (AD) crisis. The statement, which reflects the collective views and recommendations of leaders in AD research, is intended to aid the implementation of the National Alzheimer's Project Act (NAPA)'s National Plan to defeat AD. The primary public policy aims of this 10-year scientific agenda are to discover, validate, and develop: (1) a broad range of technologies, tools and algorithms for early detection of people with symptomatic AD, and asymptomatic individuals at elevated risk for AD and other dementias; and (2) a wide range of interventions to preserve and/or restore health and normal neural function, aiming to maintain independent functioning for as long as possible. The long-term scientific public health objectives of this comprehensive plan are to: (1) reduce the number of people with chronic disabling symptoms who will require prolonged care and, eventually, reduce the number of asymptomatic people at elevated risk for AD/dementia; (2) delay the onset of chronic disability for people with AD and other degenerative brain disorders; and (3) lower the cost and burden of care. The plan calls for significant expansion of research programs to identify and validate the cause(s) and pathogenesis of AD, genetic and epigenetic factors that contribute to AD risk, therapeutic targets that affect disease progression, surrogate biomarkers of AD pathobiology, and technologies for early detection of AD.
Copyright © 2012 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22748940     DOI: 10.1016/j.jalz.2012.04.003

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  9 in total

1.  The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target Populations.

Authors:  E Cavedo; S Lista; Z Khachaturian; P Aisen; P Amouyel; K Herholz; C R Jack; R Sperling; J Cummings; K Blennow; S O'Bryant; G B Frisoni; A Khachaturian; M Kivipelto; W Klunk; K Broich; S Andrieu; M Thiebaut de Schotten; J-F Mangin; A A Lammertsma; K Johnson; S Teipel; A Drzezga; A Bokde; O Colliot; H Bakardjian; H Zetterberg; B Dubois; B Vellas; L S Schneider; H Hampel
Journal:  J Prev Alzheimers Dis       Date:  2014-12

2.  Early Cognitively Based Functional Limitations Predict Loss of Independence in Instrumental Activities of Daily Living in Older Adults.

Authors:  Karen M Lau; Mili Parikh; Danielle J Harvey; Chun-Jung Huang; Sarah Tomaszewski Farias
Journal:  J Int Neuropsychol Soc       Date:  2015-09-22       Impact factor: 2.892

3.  Transitions in Care in a Nationally Representative Sample of Older Americans with Dementia.

Authors:  Christopher M Callahan; Wanzhu Tu; Kathleen T Unroe; Michael A LaMantia; Timothy E Stump; Daniel O Clark
Journal:  J Am Geriatr Soc       Date:  2015-07-22       Impact factor: 5.562

4.  Personality and risk of Alzheimer's disease: new data and meta-analysis.

Authors:  Antonio Terracciano; Angelina R Sutin; Yang An; Richard J O'Brien; Luigi Ferrucci; Alan B Zonderman; Susan M Resnick
Journal:  Alzheimers Dement       Date:  2013-05-21       Impact factor: 21.566

5.  Pharmaceutical Treatment for Alzheimer's Disease and Related Dementias: Utilization and Disparities.

Authors:  Douglas Barthold; Geoffrey Joyce; Patricia Ferido; Emmanuel F Drabo; Zachary A Marcum; Shelly L Gray; Julie Zissimopoulos
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

6.  Calibrating longitudinal cognition in Alzheimer's disease across diverse test batteries and datasets.

Authors:  Alden L Gross; Richard Sherva; Shubhabrata Mukherjee; Stephen Newhouse; John S K Kauwe; Leanne M Munsie; Leo B Waterston; David A Bennett; Richard N Jones; Robert C Green; Paul K Crane
Journal:  Neuroepidemiology       Date:  2014-11-13       Impact factor: 3.282

7.  Economic analysis of opportunities to accelerate Alzheimer's disease research and development.

Authors:  Troy J Scott; Alan C O'Connor; Albert N Link; Travis J Beaulieu
Journal:  Ann N Y Acad Sci       Date:  2014-03-27       Impact factor: 5.691

8.  A qualitative analysis of communication workflows between adult day service centers and primary care providers.

Authors:  Jie Zhong; Jonelle Boafo; Abraham A Brody; Bei Wu; And Tina Sadarangani
Journal:  J Am Med Inform Assoc       Date:  2022-04-13       Impact factor: 4.497

9.  Efficacy of Mealtime Interventions for Malnutrition and Oral Intake in Persons With Dementia: A Systematic Review.

Authors:  James C Borders; Samantha Blanke; Stephen Johnson; Andrea Gilmore-Bykovskyi; Nicole Rogus-Pulia
Journal:  Alzheimer Dis Assoc Disord       Date:  2020 Oct-Dec       Impact factor: 2.357

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.